Stay alert, beware of scamsters - know more
logosearch
Open Demat Account
hamburger
home
breadcrumbStocks
breadcrumbCohance Lifesciences Ltd Share Price
breadcrumbValuation

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.

Cohance Lifesciences Ltd Fundamentals

info2
ConsolidatedStandalone
Compare peers arrow
ConsolidatedStandalone

Market Cap

11765.85 Cr.

Face value

1.00

Book value

99.77

Div. yield

0.000

P/E ratio

58.34

P/B ratio

3.08

Debt/Eq.

0.05

Market Cap

11765.85 Cr.

Face value

1.00

Book value

99.77

Div. yield

0.00%

P/E ratio

58.34

P/B ratio

3.08

Debt/Eq.

0.05
About Cohance Lifesciences Ltd
arrow

Suven Pharmaceuticals Limited is a bio-pharmaceutical company, incorporated with the object of being engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), S Read more ▾

IndustryPharmaceuticals & Drugs
SectorHealthcare
Top subsidiaries
Sapala Organics Pvt Ltd.NJ Bio IncCohance Lifesciences Inc (Formerly Known as Suven Pharma Inc)
MANAGEMENT
right
Non Executive Independent DirectorMatangi Gowrishankar
Non Executive Independent DirectorKG Ananthakrishnan
Non Executive Independent DirectorUB Pravin Rao
Non Executive Independent DirectorJai Shankar Krishnan
Whole Time DirectorHimanshu Agarwal
left
Non Executive Independent DirectorMatangi Gowrishankar
Non Executive Independent DirectorKG Ananthakrishnan
Non Executive Independent DirectorUB Pravin Rao
Non Executive Independent DirectorJai Shankar Krishnan
Whole Time DirectorHimanshu Agarwal
ChairmanVivek Sharma
Company Secretary, Compliance Officer & Head-LegalKundan Kumar Jha
Non Executive DirectorShweta Jalan
Non Executive DirectorPankaj Patwari
Non Executive DirectorVinod Padikkal
Non Executive Independent DirectorVinod Rao
Company SecretaryK Hanumantha Rao
Non Executive Independent DirectorV Sambasiva Rao
Non Independent & Non Executive DirectorJerry Jeyasingh
Chairman & Managing DirectorVenkateswarlu Jasti
Chairman & Managing DirectorVenkateswarlu Jasti
Independent Non-Executive DirectorDG Prasad
Independent Non-Executive DirectorDeepanwita Chattopadhyay
Managing DirectorVenkateswarlu Jasti
Non Executive Independent DirectorDG Prasad
Non Executive Independent DirectorDeepanwita Chattopadhyay
ChairmanJV Ramudu
Non Executive DirectorJV Ramudu
Non Executive DirectorJerry Jeyasingh
Company SecretaryK Hanumantha Rao
Independent DirectorJai Shankar Krishnan
Non Independent DirectorVinod Padikkal
Executive ChairmanVivek Sharma
Company Secretary & Compliance OfficerKundan Kumar Jha
Non Executive Independent DirectorUB Pravin Rao
Non Executive DirectorShweta Jalan
Non Executive Independent DirectorVinod Rao
Non Executive Independent DirectorMatangi Gowrishankar
Non Executive Independent DirectorK G Ananthakrishnan
Non Executive DirectorPankaj Patwari
Managing DirectorV Prasada Raju
Non Independent & Non Executive DirectorPankaj Patwari
Non Executive Independent DirectorMatangi Gowrishankar
Non Executive Independent DirectorVinod Rao
Non Executive Independent DirectorKG Ananthakrishnan
Company SecretaryK Hanumantha Rao
Non Independent & Non Executive DirectorShweta Jalan
Managing DirectorV Prasada Raju
ChairmanAnnaswamy Vaidheesh
Non Executive Independent DirectorPravin Rao
Other detail of Cohance Lifesciences Ltd
arrow
location
Address215 Atrium, C Wing, 8th Floor, 819-821 Andheri, Kurla Road, Chakala Andheri (East), Chakala Midc ,Mumbai ,Maharashtra-400093.
phone
Telephone022-61539999
email
globe
MORE DETAILS
NSE Code17945
NSE SymbolCOHANCE
SeriesEQ
ISININE03QK01018
personal

Grow your wealth with more research recommendations

+91

Frequently Asked Questions

Cohance is a global, technology‑driven CDMO offering end‑to‑end development and manufacturing solutions across Pharma CDMO, Specialty Chemicals and API+ verticals.

Cohance serves customers in 25 countries, with exports accounting for 90.64% of turnover in the latest year.

Cohance acquired stakes in NJ Bio and Sapala Organics to expand capabilities in ADCs and oligonucleotides and changed its name to Cohance Lifesciences Limited. The Company also restated prior standalone figures following the merger of Casper Pharma Private Limited, effective January 1, 2025.